NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY), a clinical stage biopharmaceutical company developing first-in-class, anti-infective compounds in the treatment and prevention of antibiotic-resistant infections, today announced that Ron Najafi, Ph.D., Chairman and Chief Executive Officer, will deliver a corporate presentation at the 12th Annual BIO CEO & Investor Conference on Tuesday, Feb. 9 in New York City.

Dr. Najafi's presentation will take place at 2:30 p.m. ET in the Duke of Windsor room at the Waldorf Astoria. His presentation will provide a corporate overview and highlight NovaBay's clinical progress in its internal programs, as well as in its partnered programs with Alcon (NYSE: ACL) and Galderma.

An audio of the presentation will be available on NovaBay's homepage at novabaypharma.

Source
NovaBay Pharmaceuticals